11.200
+8,74%
2026-10-19
Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -27.1% | -50.2% | 1 / 3 | +3.9% | +1.21 pp | -1.51 pp | -1.5% | 0.13 | — | 113 | +3,9% | −10,2 | −24,8% | — | -68.69 | — |
| Pts | 0 | 0 | 4 | 0 | 8 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 11.200 (close price on 2026-10-19)EPS (TTM): −137,8
Financial charts
1.Revenue & growth
VND bn113Q2/26
1.Revenue & growth
VND bn113Q2/26
2.Profit & growth
VND bn-10,3Q2/26
3.Profit mix (Penman)
VND bn-36,2Q2/26
4.Margins & cost structure
%29.3%Q2/26
5.Returns & cash cycle
% · days-1.0%Q2/26
6.Earnings quality & cash
VND bn383Q2/26
7.Asset structure
VND bn2.712Q2/26
8.Funding & debt health
VND bn · times2.712Q2/26
9.Revenue backlog
VND bn127Q2/26
10.Valuation
times · %-69,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-47Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
78.2%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26